SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolargo, Inc. – ‘S-8’ on 6/22/18 – ‘EX-4.2’

On:  Friday, 6/22/18, at 3:45pm ET   ·   Effective:  6/22/18   ·   Accession #:  1437749-18-12288   ·   File #:  333-225821

Previous ‘S-8’:  ‘S-8’ on 8/26/08   ·   Latest ‘S-8’:  This Filing   ·   30 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/22/18  Biolargo, Inc.                    S-8         6/22/18    8:502K                                   RDG Filings/FA

Registration of Securities to be Offered to Employees Pursuant to an Employee Benefit Plan   —   Form S-8
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8         Registration of Securities to be Offered to         HTML     48K 
                          Employees Pursuant to an Employee                      
                          Benefit Plan                                           
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML    190K 
 3: EX-4.2      Instrument Defining the Rights of Security Holders  HTML     12K 
 4: EX-4.3      Instrument Defining the Rights of Security Holders  HTML     38K 
 5: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     11K 
 6: EX-4.5      Instrument Defining the Rights of Security Holders  HTML     46K 
 7: EX-5.1      Opinion re: Legality                                HTML     10K 
 8: EX-23.1     Consent of Experts or Counsel                       HTML      7K 


EX-4.2   —   Instrument Defining the Rights of Security Holders


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:  <>  <> 

Exhibit 4.2

 

BIOLARGO, INC.

2018 EQUITY INCENTIVE PLAN

NOTICE OF RESTRICTED STOCK UNIT AWARD

 

Unless otherwise defined herein, the terms defined in the BioLargo, Inc. (BioLargo) 2018 Equity Incentive Plan (the Plan) will have the same meanings in this Notice of Restricted Stock Unit Award and the electronic representation of this Notice of Restricted Stock Unit Award established and maintained by BioLargo or a third party designated by BioLargo (this Notice).

 

Name:

 

Address:

 

You (the Participant) have been granted an award of Restricted Stock Units (RSUs) to acquire Shares of BioLargo’s Common Stock under the Plan subject to the terms and conditions of the Plan, this Notice and the attached Restricted Stock Unit Award Agreement (the Agreement), including any applicable country-specific provisions in any appendix attached hereto (the Appendix), which constitutes part of the Agreement.

 

Grant Number:

 
   

Number of RSUs:

 
   

Date of Grant:

 
   

Vesting Commencement Date:

 
   

Expiration Date:

The earlier to occur of: (a) the date on which settlement of all RSUs granted hereunder occurs and (b) the tenth (10th) anniversary of the Date of Grant. This RSU expires earlier if Participant’s Service terminates earlier, as described in the Agreement.

   

Vesting Schedule:

[Insert applicable vesting schedule]

 

By accepting (whether in writing, electronically or otherwise) the RSUs, Participant acknowledges and agrees to the following:

 

Participant understands that Participant’s employment or consulting relationship or Service with BioLargo or a Parent or Subsidiary or Affiliate is for an unspecified duration, can be terminated at any time (i.e., is “at-will”), except where otherwise prohibited by applicable law and that nothing in this Notice, the Agreement or the Plan changes the nature of that relationship. Participant acknowledges that the vesting of the RSUs pursuant to this Notice is subject to Participant’s continuing Service as an Employee, Director or Consultant. Participant acknowledges that the Vesting Schedule may change prospectively in the event that Participant’s service status changes between full- and part-time status and/or in the event that Participant is on a leave of absence, in accordance with BioLargo’s policies relating to work schedules and vesting or as determined by the Committee. Participant also understands that this Notice is subject to the terms and conditions of both the Agreement and the Plan, both of which are incorporated herein by reference. Participant has read both the Agreement and the Plan. By accepting the RSUs, Participant consents to electronic delivery as set forth in the Agreement.

 

PARTICIPANT

BIOLARGO, INC.

         

Signature:

   

By:

 

         

Print Name:

 

 

Its:

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-8’ Filing    Date    Other Filings
Filed on / Effective on:6/22/18None on these Dates
 List all Filings 


30 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/12/24  Biolargo, Inc.                    S-1                    6:2M                                     RDG Filings/FA
 4/12/24  Biolargo, Inc.                    POS AM                 5:1.8M                                   RDG Filings/FA
 4/12/24  Biolargo, Inc.                    POS AM                 5:1.8M                                   RDG Filings/FA
 4/01/24  Biolargo, Inc.                    10-K       12/31/23   79:9.5M                                   RDG Filings/FA
11/14/23  Biolargo, Inc.                    10-Q        9/30/23   68:8.8M                                   RDG Filings/FA
 8/14/23  Biolargo, Inc.                    10-Q        6/30/23   67:8.6M                                   RDG Filings/FA
 5/17/23  Biolargo, Inc.                    10-Q        3/31/23   70:8.3M                                   RDG Filings/FA
 4/27/23  Biolargo, Inc.                    S-1                    5:1.9M                                   RDG Filings/FA
 4/27/23  Biolargo, Inc.                    POS AM                 3:1.8M                                   RDG Filings/FA
 4/14/23  Biolargo, Inc.                    POS AM                 4:1.8M                                   RDG Filings/FA
 3/31/23  Biolargo, Inc.                    10-K       12/31/22   77:9.4M                                   RDG Filings/FA
 1/11/23  Biolargo, Inc.                    S-1/A                  5:2.6M                                   RDG Filings/FA
12/23/22  Biolargo, Inc.                    S-1                    5:2.7M                                   RDG Filings/FA
11/14/22  Biolargo, Inc.                    10-Q        9/30/22   62:7.5M                                   RDG Filings/FA
 8/15/22  Biolargo, Inc.                    10-Q        6/30/22   60:7.2M                                   RDG Filings/FA
 5/16/22  Biolargo, Inc.                    10-Q        3/31/22   61:6.5M                                   RDG Filings/FA
 4/14/22  Biolargo, Inc.                    POS AM      4/13/22    2:1.9M                                   RDG Filings/FA
 4/14/22  Biolargo, Inc.                    POS AM      4/13/22    2:1.9M                                   RDG Filings/FA
 4/14/22  Biolargo, Inc.                    POS AM      4/13/22    2:1.8M                                   RDG Filings/FA
 3/31/22  Biolargo, Inc.                    10-K       12/31/21   73:9.3M                                   RDG Filings/FA
11/15/21  Biolargo, Inc.                    10-Q        9/30/21   64:8.3M                                   RDG Filings/FA
 8/16/21  Biolargo, Inc.                    10-Q        6/30/21   64:8.1M                                   RDG Filings/FA
 5/17/21  Biolargo, Inc.                    10-Q        3/31/21   64:7M                                     RDG Filings/FA
 4/08/21  Biolargo, Inc.                    POS AM      4/07/21    2:1.9M                                   RDG Filings/FA
 4/07/21  Biolargo, Inc.                    POS AM                 2:1.8M                                   RDG Filings/FA
 4/07/21  Biolargo, Inc.                    POS AM                 2:2M                                     RDG Filings/FA
 4/07/21  Biolargo, Inc.                    POS AM                 2:1.9M                                   RDG Filings/FA
 3/30/21  Biolargo, Inc.                    10-K       12/31/20   73:9.1M                                   RDG Filings/FA
11/16/20  Biolargo, Inc.                    10-Q        9/30/20   61:7.7M                                   RDG Filings/FA
 8/14/20  Biolargo, Inc.                    10-Q        6/30/20   61:7.4M                                   RDG Filings/FA
Top
Filing Submission 0001437749-18-012288   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 12:08:42.2pm ET